Harrow News and Activities
Presence
Harrow develops and sells pharmaceutical products, with a focus on eye care medicines and related treatments. It serves ophthalmologists, eye clinics, hospitals, and other healthcare providers.
Harrow products and services overview:
- Eye care drugs
- Prescription medicines
- Sterile treatments
- Surgical products
Revenue: ~$200 million
Employees: 350
Headquarters: Nashville, Canada
Harrow is one of the...
Harrow is a company listed under the stock ticker HROW (US).
Harrow has a direct presence in 2 countries.
Executives
View the org chart displaying its 26 main executives
Most searched biographies at Harrow
- Mark Baum, Chief Executive Officer and Chairman of the Board
- Lauren Silvernail, Director
- Adrienne Graves, Director
Create your alert
to follow the executive moves at Harrow.
Pharmaceuticals
Harrow has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
- Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Harrow
- Harrow Health to Announce Second Quarter 2022 Financial Results on August 9, 2022 | Harrow Health, Inc
- Harrow Health Announces Launch of IOPIDINE® 1% and MAXITROL® in the United States | Harrow Health, Inc
- Harrow Health Announces First Quarter 2022 Financial Results | Harrow Health, Inc
- Melt Pharmaceuticals Announces MELT-210 Top-Line Results of Phase 1 Pharmacokinetics (PK) Study for Procedural Sedation | Harrow Health, Inc
- Press Releases - Investor Relations - Imprimis Pharmaceuticals, Inc.
Social media about Harrow
- Harrow on Wikipedia, Google News & Yahoo Finance
- Harrow on LinkedIn, X (Twitter) & YouTube
